How does doxorubicin work?
A new mechanism involving cleavage of a transcription factor called CREB3L1 has been proposed to explain the anti-tumour effects of doxorubicin.
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2012-12-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/00387 |